Cwa Asset Management Group, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Cwa Asset Management Group, LLC
- $2.61 Billion
- Q4 2025
A detailed history of Cwa Asset Management Group, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwa Asset Management Group, LLC holds 1,799 shares of REGN stock, worth $1.25 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,799
Previous 1,615
11.39%
Holding current value
$1.25 Million
Previous $908,000
37.33%
% of portfolio
0.05%
Previous 0.04%
Shares
5 transactions
Others Institutions Holding REGN
# of Institutions
1,478Shares Held
86.6MCall Options Held
2.38MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA9.05MShares$6.27 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.86 Billion0.2% of portfolio
-
State Street Corp Boston, MA4.69MShares$3.25 Billion0.09% of portfolio
-
Dodge & Cox San Francisco, CA4.55MShares$3.16 Billion1.47% of portfolio
-
Jpmorgan Chase & CO New York, NY4.07MShares$2.82 Billion0.15% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.3B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...